Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from Oncological and continence outcomes after nerve‐sparing robot‐assisted radical prostatectomy in selected STAMPEDE‐defined high‐risk prostate cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
Effect of radical prostatectomy on survival for men with high‐risk nonmetastatic prostate cancer features selected according to STAMPEDE criteria: an EMPaCT study
10.1016/j.euo.2024.05.016 · 2024 · External reference
EAU‐EANM‐ESTRO‐ESUR‐ISUP‐SIOG guidelines on prostate cancer—2024 update. Part I: screening, diagnosis, and local treatment with curative intent
10.1016/j.eururo.2024.03.027 · 2024 · External reference
Benefits and risks of primary treatments for high‐risk localized and locally advanced prostate cancer: an international multidisciplinary systematic review
10.1016/j.eururo.2020.01.033 · 2020 · External reference
Comparison of multimodal therapies and outcomes among patients with high‐risk prostate cancer with adverse Clinicopathologic features
10.1001/jamanetworkopen.2021.15312 · 2021 · External reference
Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes
10.1136/bmj.g1502 · 2014 · External reference
Timing of radiotherapy after radical prostatectomy (RADICALS‐RT): a randomised, controlled phase 3 trial
10.1016/s0140-6736(20)31553-1 · 2020 · External reference
Timing of radiotherapy (RT) after radical prostatectomy (RP): long‐term outcomes in the RADICALS‐RT trial (NCT00541047)
10.1016/j.annonc.2024.03.010 · 2024 · External reference
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non‐inferiority trial
10.1016/s1470-2045(20)30456-3 · 2020 · External reference
Achieving quality Assurance of Prostate Cancer Surgery during Reorganisation of cancer services
10.1016/j.eururo.2015.02.028 · 2015 · External reference
10.1016/j.euo.2025.12.008
10.1016/j.euo.2025.12.008 · External reference
Negative mpMRI rules out extra‐prostatic extension in prostate cancer before robot‐assisted radical prostatectomy
10.3390/diagnostics12051057 · 2022 · External reference
Long‐term oncological outcomes after nerve‐sparing robot‐assisted radical prostatectomy for high‐risk localized prostate cancer: a single‐center, two‐arm prospective study
10.3390/diagnostics14080803 · 2024 · External reference
Erectile function, urinary continence and oncologic outcomes of neurovascular bundle sparing robot‐assisted radical prostatectomy for high‐risk prostate cancer: a systematic review and meta‐analysis
2023 · External reference
Clinical and oncological outcomes of robot‐assisted radical prostatectomy with nerve sparing vs. non‐nerve sparing for high‐risk prostate cancer cases
2019 · External reference
Characteristics of patients in SPCG‐15—a randomized trial comparing radical prostatectomy with primary radiotherapy plus androgen deprivation therapy in men with locally advanced prostate cancer
10.1016/j.euros.2022.04.013 · 2022 · External reference
Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens
10.1080/03008880510030932 · 2005 · External reference
International society of urological pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens. Working group 5: surgical margins
10.1038/modpathol.2010.155 · 2011 · External reference
Unresolved reference
External reference
10.1016/s0140-6736(07)61602-x
10.1016/s0140-6736(07)61602-x · External reference
Changing times: trends in risk classification, tumor upstaging, and positive surgical margins after radical prostatectomy ‐ results from a contemporary National Cancer Database study
10.1007/s00345-024-05262-0 · 2024 · External reference
Unresolved reference
External reference
Real‐world outcomes following biochemical recurrence after definitive therapy with a short prostate‐specific antigen doubling time: potential role of early secondary treatment
10.1038/s41391-024-00894-0 · 2024 · External reference
Best approaches and updates for prostate cancer biochemical recurrence
10.1200/edbk_351033 · 2022 · External reference
Prostate cancer ‐ major changes in the American joint committee on cancer eighth edition cancer staging manual
2017 · External reference
The impact of local staging of prostate cancer determined on MRI or DRE at time of radical prostatectomy on progression‐free survival: a will Rogers phenomenon
10.1016/j.urolonc.2022.10.023 · 2023 · External reference